Two Sigma Investments LP lifted its position in agilon health, inc. (NYSE:AGL - Free Report) by 73.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 857,867 shares of the company's stock after purchasing an additional 363,855 shares during the quarter. Two Sigma Investments LP owned about 0.21% of agilon health worth $1,630,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Barclays PLC increased its stake in agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company's stock worth $4,830,000 after acquiring an additional 214,830 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of agilon health during the fourth quarter worth about $97,000. Rhumbline Advisers increased its position in shares of agilon health by 6.2% in the fourth quarter. Rhumbline Advisers now owns 419,587 shares of the company's stock worth $797,000 after purchasing an additional 24,420 shares during the last quarter. Alberta Investment Management Corp purchased a new stake in agilon health in the fourth quarter valued at approximately $1,564,000. Finally, Ieq Capital LLC purchased a new stake in agilon health in the fourth quarter valued at approximately $26,000.
Analyst Ratings Changes
AGL has been the topic of a number of research analyst reports. Cowen reissued a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Barclays increased their target price on agilon health from $2.00 to $3.00 and gave the company an "underweight" rating in a research note on Thursday, May 8th. The Goldman Sachs Group lifted their price target on agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. TD Cowen increased their price objective on agilon health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Finally, Citigroup raised agilon health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $3.25 to $5.00 in a report on Friday, April 25th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, agilon health currently has a consensus rating of "Hold" and a consensus price target of $4.79.
Get Our Latest Report on AGL
agilon health Trading Up 2.4%
Shares of agilon health stock traded up $0.05 on Friday, hitting $2.15. The stock had a trading volume of 1,888,537 shares, compared to its average volume of 4,971,967. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The stock's 50-day simple moving average is $3.57 and its two-hundred day simple moving average is $3.19. The stock has a market cap of $890.00 million, a price-to-earnings ratio of -2.29 and a beta of 0.14.
agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the prior year, the company posted ($0.02) EPS. The firm's revenue for the quarter was down 4.5% compared to the same quarter last year. As a group, sell-side analysts predict that agilon health, inc. will post -0.59 EPS for the current year.
agilon health Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More

Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.